Northwest Biotherapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $105.7M | $26.7M | $2.2M |
| FY2025 | $128.9M | $81.3M | $3.0M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $105.7M | $26.7M | $2.2M |
| FY2025 | $128.9M | $81.3M | $3.0M |